Skip to content
Search

Latest Stories

PB Conference: Faheem Ahmed shares tips on innovation in community pharmacies

To stay afloat and remain relevant in a fast-changing world, community pharmacy will need to constantly innovate, observed innovative pharmacist Faheem Ahmed.

Speaking in the final session of the sixth annual Pharmacy Business Conference which was held online over two evenings on Sept 21 and 23, he said "innovation" -- one of the two themes of the conference alongside integration -- to him was about looking at the processes and thinking, "What can I do to move forward, to offer value to my customers?”


Ahmed said his Oxfordshire-based pharmacy, Ahmeys, offers a complete package to the patient. “We not only diagnose, manage and treat disease, we make a difference to people's lives."

His clinic offers full body health checks, blood tests as well as screening for and prevention of diseases like hypertension, diabetes, high cholesterol and the list goes on.

He added that all pharmacies can adopt this model and align with the vision of the NHS, which expects the pharmacists to play a greater role.

Ahmed opined that these innovative changes can uplift the business, benefit patients and substantially boost the pharmacist owner's bottom line.

“So essentially, by coming up with new ideas, by constantly moving forward, reinventing yourself, you can unlock the true potential of our profession,” he added.

Ahmed gave four key tips for pharmacists to innovate and uplift their businesses.

The first tip is to plan properly, focusing on the workflow and its management.

He said: “It's about making sure the plan you have in place is in line with your vision, and designed to your company aims and objectives. So you can achieve your goal.”

The second is ‘training’. It is important for pharmacists to constantly learn and develop, he said.

He added: “If you have a patient with too sensitive a certain number of symptoms, how do you differentiate between? How do you make sure the patient is safe? How do you diagnose and manage appropriately? That comes from learning.”

The third key point is focus on documentation and governance, which are vital for continuity of care.

His fourth advice is on changing the mindset to push forward and reinvent.

Ahmed said: “Don't be scared of stepping out of your comfort zone. And don't be scared of asking for help.”

He further added that marketing your business and services well using social media platforms, search engine optimization is another important aspect.

“The key thing is understanding marketing because whatever we are doing, none of this is new. I am sure there are other pharmacists who are doing this.

“So I think, it is fantastic to use social media, understanding how websites work, understanding about how search engine optimization, everything is important in setting up the services”

Taking a holistic approach and keeping these tips in consideration while setting up a service, pharmacists can unlock their potential and build a better world, Ahmed said.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less